what is a microdose glp-1 Why Microdosing? Closer Look at Reported Benefits Curious about GLP-1 microdosing and

Availability: Larger-volume orders are subject to current inventory

Diabetes type 2 has a high prevalence in the obese (BMI 25kg/m 2 ) and overweight (BMI 30kg/m 2 ) population, and these patients tend to have poor diets and sedentary lifestyles

Originally approved for type 2 diabetes and later for obesity treatment, GLP-1 and other incretin-based therapies have rapidly gained traction in both clinical and consumer spaces

As depicted in the graph below, Virginia Medicaids gross spending on GLP-1s for weight loss increased from $3.9 million to $15.63 million per quarter since 2023

This could be related to the body adjusting to the medication, changes in blood sugar levels, or individual sensitivities

Wegovy ( semaglutide ) is a prescription medication used for chronic weight management, and it is administered via a subcutaneous injection